Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bio EssenceBIOE 31 Days Payable is 12.79 as of Mar. 2026, which is 67% below its 10-year median of 38.69. GuruFocus rates BIOE with a GF Score™ of 31/100. The stock has 4 warning signs investors should review. Among 927 Drug Manufacturers companies, Bio Essence ranks worse than 98.81% on this metric.
The historical rank and industry rank for Bio Essence's Days Payable or its related term are showing as below:
BIOE'
s Days Payable Range Over the Past 10 Years
Min: 10.91 Med: 38.69 Max: 70.14
Current: 10.91
During the past 7 years, Bio Essence's highest Days Payable was 70.14. The lowest was 10.91. And the median was 38.69.
BIOE's Days Payable is ranked worse than 98.81% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs BIOE: 10.91
Bio Essence's Days Payable
declined
from Mar. 2025 (1,916.25) to Mar. 2026 (12.79).
It may suggest that Bio Essenceaccelerated paying its suppliers.
Bio Essence Days Payable Related Terms
Bio Essence Days Payable Historical Data
* Premium members only.
The historical data trend for Bio Essence's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bio Essence's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Essence Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bio Essence's Days Payable distribution charts can be found below:
* The bar in red indicates where Bio Essence's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bio Essence's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Essence (BIOE) has a Days Payable of 12.79 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bio Essence and its competitors. This is 67% below median its historical median of 38.69. Over the past decade, Bio Essence's Days Payable has ranged from 10.91 to 70.14. According to the industry distribution chart, Bio Essence ranks #916 out of 927 companies in the Drug Manufacturers industry, placing it in the top 98.8%.
Is Bio Essence's Days Payable too high?
Bio Essence's current Days Payable of 12.79 is 67% below median its 10-year median of 38.69. Over the past 10 years, this metric has ranged from a low of 10.91 to a high of 70.14. The Drug Manufacturers industry median Days Payable is 90.38. Bio Essence's value of 12.79 is 85.8% below this industry median. Based on the distribution chart, Bio Essence ranks #916 out of 927 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Bio Essence has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Bio Essence's Days Payable compare to BFRI and APUS?
According to the Drug Manufacturers industry distribution chart, Bio Essence ranks #916 out of 927 companies for Days Payable. This places Bio Essence in the lower half of its industry. The industry median Days Payable is 90.38. Bio Essence's value of 12.79 is 85.8% below this benchmark. Historically, Bio Essence's own Days Payable has ranged from 10.91 to 70.14 over the past decade. While the company's 10-year median is 38.69 vs. the industry median of 90.38, Bio Essence has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio Essence's current Days Payable of 12.79 is 85.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bio Essence and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Essence's current Days Payable is 12.79, which is 67% below median its own 10-year median of 38.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Essence stock overvalued right now?
Bio Essence (BIOE) has a current Days Payable of 12.79. The current Days Payable is 12.79, which is 67% below median its 10-year median of 38.69 and 85.8% below the Drug Manufacturers industry median of 90.38. Bio Essence's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bio Essence (BIOE), the current Days Payable is 12.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bio Essence Corp is an herbal health, diet, and nutrition company. The Company's mission is to provide herbal health, diet, and vitamin nutritional supplements. The primary focus of BEP was producing products for BEH and McBE, along with providing original equipment manufacturing and private label services to other companies. BEH targeted and developed traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. It also offered specially formulated dietary supplements and medical food. The Company operates in one business and industry segment: the manufacture / OEM and sale of health supplement products. The group's products are RED Yeast Rice Plus, Regenva, MediDrink, and Nufargo.
31GF Score
Get the complete analysis for BIOE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIOE has been successfully added to your 
